Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial

Troels Thim1, Matthias Götberg2, Ole Fröbert3

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Insights

Acute instantaneous wave-free ratio (iFR) measurements in ST-segment elevation myocardial infarction (STEMI) patients are valid for assessing nonculprit stenoses. However, agreement with follow-up iFR decreases with longer intervals post-STEMI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Physiology

Background:

  • Management of nonculprit stenoses in ST-segment elevation myocardial infarction (STEMI) is complex and often guided by angiography.
  • Acute functional assessment of these stenoses may offer valuable insights.
  • The instantaneous wave-free ratio (iFR) is a physiological index used to assess stenosis severity.

Purpose of the Study:

  • To evaluate the agreement between acute and follow-up instantaneous wave-free ratio (iFR) measurements in nonculprit stenoses of STEMI patients.
  • To determine the validity of acute iFR for ruling out hemodynamically significant stenoses.
  • To investigate the impact of the time interval between acute and follow-up assessments on iFR agreement.

Main Methods:

  • Patients with STEMI undergoing primary percutaneous coronary intervention had nonculprit stenoses assessed by iFR immediately after intervention.
  • Follow-up iFR measurements were performed at a later stage.
  • iFR < 0.90 was defined as hemodynamically significant.

Main Results:

  • A total of 120 patients with 157 nonculprit lesions were analyzed.
  • Median acute iFR was 0.89, and median follow-up iFR was 0.91.
  • Overall classification agreement between acute and follow-up iFR was 78%, with a negative predictive value of acute iFR at 89%.

Conclusions:

  • Acute iFR assessment is a valid method for excluding significant nonculprit stenoses in STEMI patients post-PCI.
  • The time delay between acute and follow-up iFR significantly impacts classification agreement.
  • Physiological changes during STEMI may contribute to discrepancies in iFR classification over time.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
468